Promyelocytic leukemia (PML) protein is a nucleoprotein that can regulate a variety of cellular stress responses. The aim of this study was to determine qualitative and quantitative changes in PML expression in preeclamptic placentae. Immunoblot, quantitative reverse transcription polymerase chain reaction (qRT-PCR), and immunohistochemistry techniques were used to determine PML gene expression and localization in normal (n ¼ 6) and preeclamptic (n ¼ 6) placentae and primary cells. Promyelocytic leukemia protein was immunolocalized within nuclei of villus mesenchyme, but largely absent in trophoblast nuclei, with a trend for increased PML reactivity in preeclamptic placenta. Immunoblot analyses of nuclear extracts confirmed relative increases (*3-fold) of PML expression in preeclamptic placentae (P < .05). Conversely, less PML messenger RNA (mRNA; *2-fold) was detected in preeclamptic versus normal placental samples. In vitro, PML expression could be increased by hypoxia in cultured endothelial cells but not trophoblast. Increased PML protein expression in preeclamptic villi suggests it could contribute to decreased vascularity and placental growth and/or function.
INTRODUCTION
The clinical syndrome preeclampsia affects 5% to 10% of primiparous women and remains one of the leading causes of maternal and perinatal morbidity and mortality. 1 Although the etiology of preeclampsia remains unclear, its pathophysiology is thought to derive from abnormal placentation, resulting in a poorly perfused placental bed 2 and the development of various cellular stresses against the developing fetus. 3 Several systemic and/or localized vascular defects have been noted in preeclampsia including generalized endothelial dysfunction, 4, 5 increased senescence of endothelial progenitor cells, 6 and an overall antiangiogenic state. [7] [8] [9] Elucidating stress-response proteins that could affect angiogenic responses may therefore be helpful in understanding the pathophysiology of preeclampsia.
Promyelocytic leukemia (PML) protein was originally identified in patients with acute PML. 10 A number of PML transcripts are produced via alternative splicing, 11 producing 7 protein isoforms (PML I-VII). 12 Each PML isoform contains an N-terminal Ring finger, 2 B-boxes, and coiled-coil domain, which designate PML as a member of the tripartite motif (TRIM) family of proteins 13 and which enables multiple posttranslational modifications. 14 Promyelocytic leukemia exists primarily as a nucleoprotein, expressed in most cells, and exhibits multifunctional characteristics. 15, 16 Promyelocytic leukemia can regulate transcription, translation, apoptosis, cell cycle progression, DNA repair, antiviral replication, cell senescence 17 and has antiangiogenic 18 and tumorsuppressive potentials. 19 The ability of PML to regulate such diverse cellular functions is likely due to its sequestration of target proteins into PML nuclear bodies 20 coupled with its expression as several different posttranslationally modified isoforms, each with potentially different functions. 17, 21 Expression of PML within the villi of normal placentae was described by Kim et al 22 to be most notable in fibroblasts, endothelial cells of fetal stem vessels, and macrophages. Temporally, expression of nuclear PML tends to increase with gestational age and remains high from approximately 31 weeks' gestation to term and suggests that PML contributes to regulating growth and development of the placenta. 22 Given the associations between cellular stresses presumed to occur in the preeclamptic placenta and the importance of nuclear PML in regulating a number of diverse and vital cell stress responses, including vascular development/function, we sought to characterize PML localization patterns and relative expression changes between normal and preeclamptic placentae.
MATERIALS AND METHODS

Patient Selection
Control placentae (n ¼ 6) were collected from women who remained normotensive throughout pregnancy and whose infants were not considered intrauterine growth restricted. Preeclamptic placentae (n ¼ 6) were collected from women meeting established criteria for preeclampsia. 1 All pregnancies were singletons, and no other fetal or maternal complications including renal disease, cardiovascular disease, or chronic maternal hypertension were evident. To avoid potential stress effects of labor and delivery 23 on PML expression, all placentae were collected from women without labor and immediately after cesarean section. Indications for cesarean section in the normal control group were previous cesarean section or malpresentation. Placentae collection protocols were approved by the Springfield Committee for Research Involving Human Subjects at Southern Illinois University School of Medicine.
Following cesarean section, placentae samples were immediately obtained from 3 separate locations on the maternal aspect of the placentae to determine regional differences in PML expression. One sample was collected from a central cotyledon (cotyledon 1), a peripheral cotyledon (cotyledon 3), and a paracentral cotyledon situated between these 2 sites (cotyledon 2). Obvious areas of vascular or villus pathology were avoided. Maternal decidua was removed from the samples; the remaining villus tissue was briefly rinsed in sterile saline and fixed in 4% paraformaldehyde for immunohistochemistry. Adjacent samples were similarly collected for protein and RNA extraction, frozen on dry ice, and stored in liquid nitrogen for protein studies or placed in RNA later (Ambion, Austin, Texas) and stored at À20 C for RNA studies.
Immunohistochemistry
Placental biopsies were paraffin embedded and 5-mm sections were deparaffinized in D-citrulline, rehydrated in a graded series of water alcohol, and then washed in phosphate-buffered saline (PBS, pH 7.2). Antigen retrieval was accomplished by boiling sections in 10 mmol/L citrate buffer (pH 6.0) for 5 minutes and allowed to cool to room temperature for 20 minutes. Sections were blocked for 1 hour with 3% bovine serum albumin (BSA)/PBS and incubated with preimmune rabbit immunoglobulin G (IgG) or rabbit polyclonal antibody against a conserved region common to all human PML protein isoforms (Santa Cruz Biotechnology, Santa Cruz, California) diluted 1:250 in 0.3% BSA/PBS overnight at 4 C. Promyelocytic leukemia immunoreactivity was detected with Alexa-fluor 568-conjugated goat antirabbit IgG antibody (1:400, Molecular Probes, Carlsbad, California) for 2 hours at room temperature. Slides were washed in PBS and coverslipped with Vectashield Hardset mounting media (Vector Laboratories, Burlington, California). Immunofluorescence was captured using an Olympus Scope-pro fluorescent microscope and image-pro 5.0 software. Threshold exposure times and camera settings were held constant to those obtained with nonimmune rabbit IgG immunofluorescence.
Immunoblots for PML Expression
Villus tissue samples were thawed in PBS supplemented with complete protease inhibitor cocktail (Calbiochem, San Diego, California) and phosphatase inhibitors. Tissue homogenization and nuclear fractionation were performed according to instructions (Nuclear Extract Kit, Active Motif, Carlsbad, California) as previously described, 24 and protein concentrations in the lysates were determined using D C Protein Assay (Bio-Rad, Hercules, California). Nuclear lysates (30 mg) were resolved by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes. Membranes were blocked with 5% BSA in Tris-buffered saline containing 0.05% Tween-20 (TBST) and incubated with rabbit anti-PML antibody (Santa Cruz Biotechnology; 1:1000) diluted in 1% BSA-TBST overnight at 4 C. Membranes were washed and incubated with anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibody (Jackson Immu-noResearch Laboratories, West Grove, Pennsylvania; 1:5000). Promyelocytic leukemia immunoreactivity was detected by chemiluminescence (Amersham Biosciences, Piscataway, New Jersey). We found that nuclear lamin A/C protein expression can fluctuate under changing O 2 conditions (data not shown). However, b-actin is expressed in the nuclear compartment 25 and does not fluctuate under hypoxia, which enables us to normalize relative PML densitometry values to b-actin reactivity as described. 24 Quantification of PML reactivity was determined by comparing ratios of PML/b-actin for each cotyledon in preeclamptic placenta to ratios from a matched normal placenta analyzed on the same membrane.
Quantitative RT-PCR
One microgram of total RNA was reverse transcribed into complementary DNA (cDNA) using iScript (Bio-Rad) according to the manufacturer's instructions. Respective sense and antisense primers for the human genes analyzed are glyceraldehyde 3-phosphate dehydrogenase (GAPDH): 5 0 -GAAGGTGAAGGTCGGAGTCAA-3 0 and 5 0 -CAGAGTTAAAAGCAGCCCTGG-3 0 ; glial cells missing-1 (GCM-1): 5 0 -GTCAGGCTCTCAAATC-3 0 and 5 0 -CCACTCTAGTATTTCCACCC-3 0 ; placental growth factor (PGF): 5 0 -AGAAGATGCCGGTCAT-GAG-3 0 and 5 0 -ACACTTCCTGGAAGGGTAC-3 0 ; PML: 5 0 -CTACGCTGACCAGCATCTAC-3 0 and 5 0 -CTGATGTCGCACTTGAGCTC-3 0 ; and sflt-1: 5 0 -AGGGGAAGAAATCCTCCAGA-3 0 and 5 0 -CAA-CAAACACAGAGAAGG-3 0 . Specificity of the primers and validity of expected amplicons were confirmed by gel electrophoresis, and primers for PGF, PML, and sflt-1 were designed to recognize conserved regions of each target (data not shown). Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed using iQSYBR Green PCR supermix (Bio-Rad) and a melt curve analyses were included after each qRT-PCR to confirm product integrity. Relative changes in gene expression between the preeclamptic and normal samples were determined using the DDCT method 26 as described. 24 
In Vitro Manipulation of PML Expression in Human Cytotrophoblast and Umbilical Vein Endothelial Cells and Primary Trophoblast
Human cytotrophoblast and umbilical vein endothelial cells (HUVEC) were isolated from normal term placentae as previously described. 24, 27 Cell cultures were treated under hypoxic conditions (*1% O 2 ) as previously described 24 or treated with rhInterferon-b (200 U/mL) for 24 hours. Interferon-b is a well-established inducer of PML expression. 28 Nuclear protein extracts were processed for immunoblotting as above. For immunohistochemical studies, parallel cultures were fixed with ice-cold acetone/methanol (50% v/v) and blocked with 2% BSA/PBS. Rabbit anti-PML or nonimmune IgG (1:250) in 2% BSA/PBS was reacted overnight at 4 C. Cells were rinsed and PML immunoreactivity detected with Alexafluor 568-conjugated secondary antibody and photographed as above.
Statistical Analyses
Nonparametric Mann-Whitney tests were used to compare clinical parameters between the normal and preeclamptic women at delivery. Wilcoxon signed rank test was used for the relative differences in PML expression by Western blot between the normal and preeclamptic samples, and Kruskal-Wallis nonparametric analysis of variance (ANOVA) was used to evaluate expression differences between cotyledon samples. A 1-sample t test was used to analyze the relative differences in gene expression between the normal (set to 100) and the preeclamptic samples. A P value .05 was considered statistically significant.
RESULTS
Clinical characteristics of normotensive and preeclamptic pregnancies are summarized in Table 1 . There was no significant difference in maternal age or maternal body mass index between the 2 study groups. Maternal systolic and diastolic blood pressures were significantly higher in the preeclamptic group at delivery. Mean gestational age in the normotensive patients was *39 weeks, while the preeclamptic patients were delivered at a significantly earlier gestational age (*31 weeks). Because of the earlier gestational age at delivery, there was a significant difference in birth weights between the groups.
Nuclear PML was localized primarily within the fetal stem vessel endothelial cells and stroma cells of the villi (Figure 1) , with little to no PML immunoreactivity in villus cytotrophoblast or syncytiotrophoblast. These findings are in qualitative agreement with previous studies. 22 In placentae from normal term deliveries, the number and distribution of cells showing nuclear PML body expression was fairly uniform between different regions of the same placentae. In contrast, preeclamptic placentae exhibited varied regional differences in PML. There also appeared to be relatively greater PML immunoreactivity in preeclamptic placenta than in normal samples ( Figure 1 ), specifically in vascular endothelial and stroma cells. The relative differences in PML expression are more evident upon comparison between the central, paracentral, and peripheral regions of the placentae. There were relatively smaller differences observed between the paracentral ( Figure 1B) cotyledons of preeclamptic samples and comparative sections from normal placentae. However, there was a trend for increased visual differences in PML expression within sections collected from the central and peripheral cotyledons of the preeclamptics (Figure 1A and C).
Promyelocytic leukemia nuclear bodies from preeclamptic and normal placentae localized as diffuse or speckled patterns within nuclei. Particularly notable was the heterogeneous PML nuclear body distribution patterns within endothelial cells of the fetal stem vessels. Some trophoblast nuclei sequestered within syncitial knots demonstrated very weak PML nuclear body immunoreactivity (data not shown); however, this reactivity did not seem to significantly vary between normal and preeclamptic placentae.
Given that the density differences between samples could influence interpretation of the immunohistochemistry findings, we used a more quantitative immunoblot approach to confirm differences between the clinical samples (Figure 2A ). Multiple bands corresponding to potentially different PML isoforms or modified isoforms were detected. These findings are typical for PML protein expression as alternative splicing of the PML gene results in several specific PML protein isoforms, and posttranslational modifications of PML produce multiple banding patterns. 21 Promyelocytic leukemia bands between *60 and 120 kD were used for quantitative analyses between samples. Normalized PML to b-actin ratios in preeclamptic placenta were compared to normalized ratios from control placentae analyzed on the same blot. Promyelocytic leukemia expression was elevated in central, paracentral, and peripheral regions of preeclamptic placentae, with each single region demonstrating some variation ( Figure  2B ). However, variations between regions were not significantly different (Kruskal-Wallis ANOVA, P > .5). Mean normalized PML expression across all regions in preeclamptic placentae was *3-fold higher (P ¼ .03) than in control placentae ( Figure 2B) . Thus, the Western blot data generally support the more subjective spatial differences detected by immunohistochemistry.
Real-time RT-PCR was used to assess differences in PML mRNA expression between the normal and preeclamptic placentae (Figure 3 ). As control, differences in mRNA expression of genes known to be dysregulated in preeclampsia were also determined. Despite increased PML protein detected by immunoblots, PML mRNA expression was significantly decreased in preeclamptic samples. Relative mRNA expression of the angiogenic growth factor, PGF, and its transcriptional regulator in trophoblast, GCM-1, 24 were also significantly decreased in the preeclamptic samples as described. 29, 30 In contrast, relative mRNA expression of the soluble receptor for PGF and vascular endothelial growth factor was significantly increased as expected. 31 The control genes results in preeclamptic samples confirm the validity of the PML mRNA findings. Due to the presumed association between hypoxic stress and preeclampsia, we determined whether low oxygen tension could contribute to increased PML protein expression in vascular endothelial cells or whether PML expression could be induced in primary trophoblast (Figure 4 ). Promyelocytic leukemia bodies were readily evident in HUVEC cultured under standard conditions ( Figure 4A ). Exposure to interferon b, a known inducer of PML, 28 produced a marked increase in the expression and nuclear organization of the PML bodies. Low oxygen tension appeared to increase the total PML immunoreactivity; however, PML nuclear bodies were less structured than those induced by interferon b. In contrast, primary trophoblast exhibited very little nuclear PML expression, which is in agreement with the placental immunohistochemistry findings (Figure 1 ). Exposure of trophoblast to interferon b or low oxygen conditions did not significantly alter PML body immunoreactivity ( Figure 4A) .
Immunoblotting was performed on nuclear extracts from these cultures to more accurately assess quantitative changes in PML expression ( Figure 4B ). Exposure of HUVEC to 1% O 2 resulted in an increase in total PML expression with strong induction of isoforms at *60 and *115 kD, qualitatively similar to that induced by interferon b. Primary term trophoblast exhibited less nuclear PML protein expression than HUVEC (the trophoblast blot is overexposed to highlight comparisons between treatments within these cells). Importantly, in contrast to the responses in HUVEC, little alteration in expression and/or distribution of PML in primary trophoblast could be detected. There was a relatively small increase in the major PML band at *75 kD; however, neither interferon b nor hypoxia resulted in induction of the *115 kD or *60 kD PML isoforms that were induced by these treatments in the HUVEC cultures. The immunoblotting findings are in agreement with the immunohistochemical Figure 2 . Nuclear promyelocytic leukemia (PML) protein expression in normal and preeclamptic placentae. A, Representative immunoblot of PML expression in normal and preeclamptic placentae. Nuclear lysates were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to nitrocellulose, and probed with anti-PML. Blots were stripped and reprobed with antibodies to b-actin to control for loading consistency. B, Increased PML expression in preeclamptic placental lysates. Normalized PML/b-actin expression in uncomplicated pregnancies was set to 1.0 (n ¼ 6 for each group, except cotyledon 3, where n ¼ 5). Normalized PML expression from all findings, indicating that PML expression patterns within the trophoblast remain relatively consistent. Collectively, these results suggest that stressors such as low oxygen tension and type I interferons can increase PML expression in vascular endothelial cells. In contrast, trophoblasts express little endogenous PML and they are relatively impervious to PML induction by these stressors.
DISCUSSION
Preeclampsia is often reported to be associated with exposure of the placenta to various stress conditions, in particular hypoxic stress. 32 The goal of this investigation was to compare the expression and distribution patterns of a significant stress response protein, PML, in preeclamptic placentae. Increased PML protein expression was identified via immunohistochemical analyses in the placentae of preeclamptic patients relative to normotensive term control placentae. Increased PML immunoreactivity was most noticeable within cells of the villus core (macrophages, endothelial cells, fibroblasts) rather than in the trophoblast cells. Indeed, little PML reactivity could be detected within trophoblast cells in vivo or in vitro. Increased PML isoform expression was evident in nuclear extracts of preeclamptic placentae in spite of less PML mRNA being detected. In vitro, PML expression and nuclear organization can be altered in endothelial cells, but not trophoblast, by low oxygen or interferon b.
Our study is consistent with previous reports 22 in that PML expression is detectable in normal placenta localizing within diffuse or speckled nuclear bodies throughout gestation. This heterogeneous morphology is limited to specific cell types of the villus stroma, including capillary endothelial cells, villus stromal fibroblasts, and resident macrophages but not villus cytotrophoblast or syncytiotrophoblast. 22 Outside of the villi, PML protein expression had been described in amnion cells, trophoblast Figure 3 . Expression of promyelocytic leukemia (PML) messenger RNA (mRNA) is decreased in preeclamptic placentae. Total RNA was extracted from villus samples of normal and preeclamptic placentae and relative gene expression evaluated by real-time reverse transcription polymerase chain reaction (RT-PCR) for PML, placental growth factor (PGF), glial cells missing-1 (GCM-1), and sflt-1. Relative gene expression in the preeclamptic placentae was normalized to levels in the pool of normal placentae. All findings were significantly different from normals (set to 100%). giant cells, and intermediate trophoblast within the decidua. 22 We did not have an opportunity to study these extravillous locations in our archived samples.
Temporally, PML protein expression in normal placentae has been reported to increase as gestation proceeds to term. 22 Our study extends these observations by including preeclamptic samples. Whereas PML protein levels were very low at less than 31 weeks' gestational age in normal placentae, 22 our preeclamptic samples at 28 to 34 weeks demonstrated relatively greater nuclear PML protein expression than did control samples. Therefore, we anticipate that differences in PML expression could be larger than depicted here if normal placenta samples from 28 to 34 weeks' gestation were available for study. Because stresses of labor may induce changes in PML expression, our study examined PML expression in preeclamptic placentae from unlabored patients. Thus, it was imperative to obtain control placentae from patients who underwent cesarean delivery in the absence of labor. Ideally, it would be preferable if such deliveries could be matched to the gestational age of the preeclamptic group. However, there are very few, if any, circumstances in which normal pregnant unlabored patients are delivered by elective cesarean delivery at the same average gestational age as the preeclamptic group. Larger studies are needed to determine whether the changes in PML expression correlate with severity of preeclampsia and/ or whether other clinical parameters (intrauterine growth restriction [IUGR], diabetes, smoking, etc) are associated with altered PML expression patterns in the villi.
We found a dissociation in the relative expression levels of PML protein and mRNA in the preeclamptic placenta samples. This is likely due to posttranslational modifications that alter PML protein stability. 33 For example, PML protein can be phosphorylated and/or sumoylated and protected from degradation, and exogenous stimuli have been shown to increase or decrease PML protein levels independent of mRNA levels in different cell types. 34, 35 Interestingly, we did not detect prominent levels of PML protein in isolated primary trophoblast nor could we induce PML protein expression in trophoblast with interferon b. Posttranslational modifications may explain these results. Sumoylation by the small ubiquitin-like modifier (SUMO)-1 protein extends the half-life of PML by inhibiting ubiquitination. 21 Sumoylation is also required for nuclear body formation, as PML that is diffusely localized within the nucleoplasm lacks SUMO-1 modification. 36 It has recently been shown that SUMO-1 is degraded by a highly expressed trophoblast-specific SUMO protease, SUMO1/sentrin/SMT3 specific peptidase 2 (SENP-2), a protein necessary for trophoblast differentiation and placentation. 37 Thus, we speculate that the relatively low and stable expression of PML in trophoblast may be due to SENP-2 activity. Whether posttranslational modifications are responsible for altering PML protein expression and/or functional activity in the preeclamptic tissues is not known but suggest future investigations of sumoylation in preeclampsia should be considered.
Recently, it was shown that preeclamptic placentae not complicated by IUGR are affected by increased endothelial progenitor cell senescence and reduced function. 6 Overexpression of PML has been shown to cause increased fibroblast senescence 38 and can function to inhibit angiogenesis. 18 Thus, it could be that increased endothelial cell nuclear expression of PML during preeclampsia contributes to the relative senescence of these cells. Similarly, it is possible that increased expression of PML in placental macrophages (Hofbauer cells) could affect placental development and vascularity, as these cells have been shown to colocalize near fetal stem vessels and express numerous growth factors, including angiogenic growth factors, that can regulate trophoblast and villus branching morphogenesis. 39, 40 Expression of the angiogenesis-related genes used in this study (PGF, sflt-1) was significantly different between normal and preeclamptic samples, as expected. Although these genes were used primarily to validate the PML mRNA findings, both can be expressed in vascular endothelial cells. The possible relationship between the expression levels of these genes and changes in PML expression in preeclampsia is unknown. Nonetheless, it is conceivable that differences in PML expression or function within several different cells of the villus core may contribute to the inadequate placentation of preeclampsia. Furthermore, such effects may be independent of trophoblast in that alterations in PML expression/localization were not readily evident in these cells.
Promyelocytic leukemia function is highly studied in cancer and viral infection, but its significance in other disease conditions is relatively unknown. In the context of preeclampsia, PML nuclear bodies may interfere with angiogenic responses through inhibition of mammalian target of rapamycin (mTOR) activation, a mechanism that limits angiogenic responses in both neoplastic and ischemic conditions. 41 Additionally, it may reduce hypoxia-induced angiogenesis through inhibition of hypoxia-inducible factor 1 a (HIF-1a) protein synthesis. 18 In correlative support of this, increased expression of HIF-1a protein is most notable in syncytiotrophoblast of preeclamptic placentae, 42 where there is relatively little PML expression (current study and reference 22). Thus, ischemic stress may enable increased HIF-1a production but PML-mediated inhibition of HIF-1a protein translation may result in heterogenous expression of HIF-1a protein between different cell types. Because HIF-1a protein expression is not thought to be increased in IUGR, 43 PML regulatory pathways should also be investigated in other obstetrical complications associated with hypoxia.
In summary, our findings agree with previous studies showing PML expression within cells of the villus core, but not trophoblast, in normal placentae. 22 We extended these studies to show that nuclear PML expression is elevated within these cells, but not trophoblast, in preeclamptic placentae. Furthermore, PML expression is inducible by hypoxia or interferon b treatments in vascular endothelial cells, but not trophoblast. Our results, coupled with others' showing PML protein can adversely affect hypoxia-mediated angiogenic responses, 18 provide a novel suggestion that increased PML expression may contribute to inadequate placental vascularity associated with preeclampsia.
